Fauci, A. S. 2008. Multidrug-resistant and extensively drug-resistant tuberculosis: The National Institute of Allergy and Infectious Diseases research agenda and recommendations for priority research. Journal of Infectious Diseases 197(11)1493–1498.

Frieden, T. R., P. I. Fujiwara, R. M. Washko, and M. A. Hamburg. 1995. Tuberculosis in New York City—turning the tide. New England Journal of Medicine 333(4):229–233.

Friedland, G. 2008. HIV/MDR-XDR-TB: Implications. Speaker presentation at the Institute of Medicine Workshop on Addressing the Threat of Drug-Resistant Tuberculosis, November 5, Washington, DC.

Gandhi, N. R., A. Moll, A. W. Sturm, R. Pawinski, T. Govender, U. Lalloo, K. Zeller, J. Andrews, and G. Friedland. 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368:1575–1580.

Gandhi, N. R., N. S. Shah, J. R. Andrews, V. Vella, A. P. Moll, M. Scott, P. Baberia, C. Marra, U. Lalloo, and G. Friedland. 2009. High early mortality among HIV-infected patients with multidrug-resistant (MDR) or extensively drug-resistant tuberculosis (XDR TB) in Rural South Africa. Poster presentation at 16thConference on Retroviruses and Opportunistic Infections, Montreal.

Gao, Q. 2008. Transmission of MDR/XDR tuberculosis in Shanghai. Speaker presentation at the Institute of Medicine Workshop on Addressing the Threat of Drug-Resistant Tuberculosis, November 5, Washington, DC.

Gelmanova, I. Y., S. Keshavjee, V. T. Golubchikova, V. I. Berezina, A. K. Strelis, G. V. Yanova, S. Atwood, and M. Murray. 2007. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: Non-adherence, default and the acquisition of multidrug resistance. Bulletin of the World Health Organization 85(9):649–732.

Ginsberg, A. 2008. TB drug development: Pipeline realities. Speaker presentation at the Institute of Medicine Workshop on Addressing the Threat of Drug-Resistant Tuberculosis, November 5, Washington, DC.

Global Health Forecasting Working Group. 2007. A risky business: Saving money and improving global health through better demand forecasts. Washington, DC: CGD.

Goldfeld, A. 2008. Drug and health care delivery: A perspective from Cambodia and Ethiopia. Speaker presentation at the Institute of Medicine Workshop on Addressing the Threat of Drug-Resistant Tuberculosis, November 5, Washington, DC.

IOM (Institute of Medicine). 2000. Ending neglect: The elimination of tuberculosis in the United States. Washington, DC: National Academy Press.

Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: Guide for the level III laboratory. Atlanta, GA: CDC. Pp.57–63.

Keshavjee, S. 2008. Stemming the tide of multidrug-resistant tuberculosis: Major barriers to addressing the growing epidemic. Speaker presentation at the Institute of Medicine Workshop on Addressing the Threat of Drug-Resistant Tuberculosis, November 5, Washington, DC.

Keshavjee, S., and K. Seung. 2008. Stemming the tide of multidrug-resistant tuberculosis: Major barriers to addressing the growing epidemic. http://www.iom.edu/Object.File/Master/60/204/IOM_MDRTB_whitepaper_2009_01_14_FINAL_Edited.pdf (accessed February 17, 2009).

Lucas, S. B., A. Hounnou, C. Peacock, A. Beaumel, G. Djomand, J. M. N’Gbichi, K. Yeboue, M. Honde, M. Diomande, C. Giordano, et al. 1993. The mortality and pathology of HIV infection in a West African City. AIDS 7(12):1569–1579.

Ministry of Health of the People’s Republic of China. 2000. Nationwide random survey for the epidemiology of tuberculosis in 2000: Ministry of Public Health of the People’s Republic of China, 2000. Beijing, China: Ministry of Health of the People’s Republic of China.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement